← Back
$VNDA All transactions

Vanda Pharmaceuticals Inc.

▼ SELL

$ Value

$351K

Shares

42,431

Price

$8

Filed

Mar 4

Insider

Name

Birznieks Gunther

Title

SVP, Business Development

CIK

0001702031

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

494,197

Footnotes

Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.085 to $8.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Filing Info

Accession No.

0001702031-26-000002

Form Type

4

Issuer CIK

0001347178

Birznieks Gunther's History

Date Ticker Type Value
2026-03-02 VNDA $351K
2026-02-18 VNDA A $0

Other Insiders at VNDA (90d)

Insider Bought Sold Last
Polymeropoulos Mihael Hristos
President and CEO
$1.3M 2026-03-02
Birznieks Gunther
SVP, Business Development
2026-02-18
Williams Timothy
SVP & General Counsel
$351K 2026-03-02
Wijkstrom Joakim
SVP, Chief Marketing Officer
$255K 2026-03-02
Moran Kevin Patrick
SVP, CFO & Treasurer
$351K 2026-03-02
Honore Tage $241K 2026-02-23